Published in PLoS Med on March 30, 2010
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Increasing value and reducing waste: addressing inaccessible research. Lancet (2014) 4.83
The association between exaggeration in health related science news and academic press releases: retrospective observational study. BMJ (2014) 3.23
Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol (2015) 2.93
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol (2010) 2.72
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother (2010) 2.27
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
A search filter for increasing the retrieval of animal studies in Embase. Lab Anim (2011) 2.09
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med (2013) 1.92
The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med (2010) 1.86
Human sensory neurons: Membrane properties and sensitization by inflammatory mediators. Pain (2014) 1.69
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med (2011) 1.52
A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease. Oxid Med Cell Longev (2017) 1.39
The ethical dimension in published animal research in critical care: the public face of science. Crit Care (2014) 1.39
A concerted appeal for international cooperation in preclinical stroke research. Stroke (2013) 1.32
Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes. Ann Neurol (2013) 1.26
A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib. Elife (2015) 1.20
A step-by-step guide to systematically identify all relevant animal studies. Lab Anim (2011) 1.16
Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol (2014) 1.15
Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol (2013) 1.14
Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant (2014) 1.14
Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke. PLoS Biol (2016) 1.14
The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect (2014) 1.13
Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. Immunity (2016) 1.12
Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci (2013) 1.12
Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab (2014) 1.11
Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis. PLoS Biol (2014) 1.10
Reporting animal studies: good science and a duty of care. PLoS Biol (2010) 1.07
In vivo animal stroke models: a rationale for rodent and non-human primate models. Transl Stroke Res (2013) 1.07
Revitalizing psychiatric therapeutics. Neuropsychopharmacology (2014) 1.05
Bioengineered human tumor within a bone niche. Biomaterials (2014) 1.05
Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron (2013) 1.05
Look back in anger - what clinical studies tell us about preclinical work. ALTEX (2013) 1.04
Derivation of multivariate syndromic outcome metrics for consistent testing across multiple models of cervical spinal cord injury in rats. PLoS One (2013) 1.03
Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disorders. Neural Plast (2012) 1.03
Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis. PLoS Pathog (2014) 1.02
Open science and reporting animal studies: who's accountable? PLoS Biol (2014) 1.01
Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci (2013) 1.01
"Orphan" retrogenes in the human genome. Mol Biol Evol (2012) 1.00
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis. PLoS One (2015) 1.00
Approaching the in vitro clinical trial: engineering organs on chips. Lab Chip (2014) 0.98
From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine. EPMA J (2013) 0.98
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation. Circ Res (2017) 0.96
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review. Int J Epidemiol (2015) 0.95
Tissue-engineered models of human tumors for cancer research. Expert Opin Drug Discov (2015) 0.95
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types. J Biol Chem (2013) 0.93
Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies. Neuromuscul Disord (2011) 0.92
Controlling complexity: the clinical relevance of mouse complex genetics. Eur J Hum Genet (2013) 0.92
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders. Psychopharmacology (Berl) (2013) 0.91
Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury. Stem Cell Reports (2017) 0.91
Do stroke models model stroke? Dis Model Mech (2012) 0.91
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol. Syst Rev (2014) 0.91
The risk-escalation model: a principled design strategy for early-phase trials. Kennedy Inst Ethics J (2014) 0.90
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery. Tissue Eng Part B Rev (2013) 0.90
Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: systematic review and meta-analysis. J Cereb Blood Flow Metab (2012) 0.89
The methodological quality of animal research in critical care: the public face of science. Ann Intensive Care (2014) 0.89
Of mice and men: what rodent models don't tell us. Cell Mol Immunol (2013) 0.88
Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol (2014) 0.88
The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it? ILAR J (2014) 0.88
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 0.88
Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools. BMC Med Res Methodol (2014) 0.88
Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis (2011) 0.87
Mechanism based approaches for rescuing and enhancing cognition. Front Neurosci (2013) 0.87
The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J (2014) 0.87
Photothrombosis-induced infarction of the mouse cerebral cortex is not affected by the Nrf2-activator sulforaphane. PLoS One (2012) 0.87
Oral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood. PLoS Pathog (2014) 0.87
The flaws and human harms of animal experimentation. Camb Q Healthc Ethics (2015) 0.86
Intervention in the context of development: pathways toward new treatments. Neuropsychopharmacology (2014) 0.86
Bias in the reporting of sex and age in biomedical research on mouse models. Elife (2016) 0.86
Inter-species inference of gene set enrichment in lung epithelial cells from proteomic and large transcriptomic datasets. Bioinformatics (2014) 0.86
Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata. J Invest Dermatol (2011) 0.86
Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp (2014) 0.86
Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain. Arthritis Res Ther (2011) 0.86
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Sci Rep (2015) 0.86
Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI. J Am Soc Nephrol (2015) 0.85
Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model. PLoS One (2015) 0.85
Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis. Biomed Res Int (2015) 0.85
The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages. Front Microbiol (2014) 0.85
Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia. PLoS One (2014) 0.85
Reporting of preclinical tumor-graft cancer therapeutic studies. Cancer Biol Ther (2012) 0.85
NSF workshop report: discovering general principles of nervous system organization by comparing brain maps across species. Brain Behav Evol (2014) 0.85
The Human Model: Changing Focus on Autism Research. Biol Psychiatry (2015) 0.85
Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies. PLoS One (2015) 0.85
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
In cold blood: intraarteral cold infusions for selective brain cooling in stroke. J Cereb Blood Flow Metab (2014) 0.84
Improving transparency and ethical accountability in animal studies: three ways to link ethical approvals to publications. EMBO Rep (2010) 0.84
Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. Lab Chip (2014) 0.84
The evolution of traumatic brain injury in a rat focal contusion model. NMR Biomed (2012) 0.84
A systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic stroke. Sci Rep (2015) 0.83
Evolutionary profiling reveals the heterogeneous origins of classes of human disease genes: implications for modeling disease genetics in animals. BMC Evol Biol (2014) 0.83
Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma? Neuropsychopharmacology (2016) 0.83
Microfluidic organ-on-chip technology for blood-brain barrier research. Tissue Barriers (2016) 0.83
Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research. Alzheimers Res Ther (2015) 0.83
Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior. Neurosci Biobehav Rev (2014) 0.83
Translational challenges of animal models in Chagas disease drug development: a review. Drug Des Devel Ther (2015) 0.83
The Researchers' View of Scientific Rigor-Survey on the Conduct and Reporting of In Vivo Research. PLoS One (2016) 0.83
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med (2004) 14.78
Myocardial reperfusion injury. N Engl J Med (2007) 13.41
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke (1999) 6.18
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Blinding in randomised trials: hiding who got what. Lancet (2002) 5.47
Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ (2006) 5.05
Allocation concealment in randomised trials: defending against deciphering. Lancet (2002) 4.71
Translation of research evidence from animals to humans. JAMA (2006) 4.48
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
Sample size calculations in randomised trials: mandatory and mystical. Lancet (2005) 4.30
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler (2008) 4.05
Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J (2002) 3.96
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci (2007) 3.67
Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med (2003) 3.64
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ (1995) 3.35
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
The need for randomization in the study of intended effects. Stat Med (1984) 3.01
Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab (2006) 2.99
Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke (2008) 2.98
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology (1994) 2.95
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke (2002) 2.87
Clinical practice. Acute ischemic stroke. N Engl J Med (2007) 2.76
Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis (2007) 2.33
Translating animal research into clinical benefit. BMJ (2007) 2.25
Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke (2002) 2.25
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke (1999) 1.78
Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. J Card Fail (2003) 1.64
Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab (2006) 1.59
Progesterone for the treatment of experimental brain injury; a systematic review. Brain (2007) 1.54
A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide (2005) 1.36
Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med (2005) 1.34
Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke (2009) 1.32
Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res (2007) 1.30
Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer (2003) 1.30
Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia. J Neurol (2005) 1.23
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerations. Mov Disord (2009) 1.18
Intrauterine growth restriction in a rodent model and developmental programming of the metabolic syndrome: a critical appraisal of the experimental evidence. Placenta (2008) 0.99
Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies. Int J Radiat Biol (2006) 0.97
Early complications of ischemic stroke. Curr Treat Options Neurol (2008) 0.84
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler (2010) 2.73
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med (2014) 2.05
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord (2011) 1.64
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab (2009) 1.45
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42
Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods (2006) 1.41
Inflammation following stroke. J Clin Neurosci (2006) 1.40
Surveying the literature from animal experiments: systematic review and meta-analysis are important contributions. BMJ (2005) 1.38
Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res (2005) 1.35
Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J Cereb Blood Flow Metab (2010) 1.35
Treatment of intracerebral hemorrhage in animal models: meta-analysis. Ann Neurol (2011) 1.26
Animal models of bone cancer pain: systematic review and meta-analyses. Pain (2013) 1.22
How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol (2011) 1.22
Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice. Br J Pharmacol (2009) 1.18
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke (2014) 1.13
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis (2007) 1.13
Greater incidence of both fatal and nonfatal strokes in disadvantaged areas: the Northeast Melbourne Stroke Incidence Study. Stroke (2006) 1.13
Preclinical studies of human disease: time to take methodological quality seriously. J Mol Cell Cardiol (2011) 1.13
Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke (2012) 1.11
Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci (2007) 1.07
Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing. J Cereb Blood Flow Metab (2010) 1.02
Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain (2012) 1.00
Inducing stroke in aged, hypertensive, diabetic rats. J Cereb Blood Flow Metab (2010) 0.97
Evaluation of combination therapy in animal models of cerebral ischemia. J Cereb Blood Flow Metab (2012) 0.97
Long-term stimulation of neural progenitor cell migration after cortical ischemia in mice. Stroke (2011) 0.96
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review. Int J Epidemiol (2015) 0.95
An enriched environment improves sensorimotor function post-ischemic stroke. Neurorehabil Neural Repair (2010) 0.94
Comparison of inflammation in the brain and spinal cord following mechanical injury. J Neurotrauma (2008) 0.93
Reprint: Good laboratory practice: preventing introduction of bias at the bench. Int J Stroke (2009) 0.93
The resistance to ischemia of white and gray matter after stroke. Ann Neurol (2004) 0.93
Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. PLoS One (2013) 0.92
Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury. Stroke (2005) 0.91
Hypothermia prior to decompression: buying time for treatment of acute spinal cord injury. J Neurotrauma (2010) 0.91
Salvaging the ischaemic penumbra: more than just reperfusion? Clin Exp Pharmacol Physiol (2002) 0.91
Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke (2004) 0.91
The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals. Int J Stroke (2012) 0.90
Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke. Syst Rev (2013) 0.90
Improving the efficiency of the development of drugs for stroke. Int J Stroke (2012) 0.89
Interventions for post-stroke fatigue. Cochrane Database Syst Rev (2015) 0.87
The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J (2014) 0.87
Scope of preclinical testing versus quality control within experiments. Stroke (2009) 0.87
Intracanal pressure in compressive spinal cord injury: reduction with hypothermia. J Neurotrauma (2011) 0.85
Characterization of fluoromisonidazole binding in stroke. Stroke (2006) 0.84